10 Big Stocks Cheer 52-Week Highs as S&P Closes Above 1200 Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Kimberly-Clark Corporation (NYSE:KMB): Up 0.76% to $71.99. ... |
